This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Saeed Ahmad, MD, FRCP, FCCP
Fairmont, WVa

Arch Intern Med. 1995;155(17):1912.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Pollak et al¹ described elevation of serum total cholesterol and triglyceride levels during amiodarone therapy. I observed a similar metabolic side effect in a patient treated with amiodarone.

Report of a Case.

A 41-year-old man had been taking amiodarone (400 mg/d) for more than 1 year to treat nonsustained ventricular tachyarrhythmias due to ischemic heart disease. He had been undergoing laboratory tests, including thyroid, renal, hepatic, and lipid profiles, and chest radiography every 6 months, and the results of both had been within normal ranges. The lipid profile had revealed a cholesterol level of 5.20 mmol/L (200 mg/dL), a triglyceride level of 2.82 mmol/L, and a high-density lipoprotein level of 1.00 mmol/L (40 mg/dL). A recent 6-month blood chemistry profile revealed a cholesterol level of 9.05 mmol/L (350 mg/dL), a triglyceride level of 7.24 mmol/L (280 mg/dL), a high-density lipoprotein level of 0.78 mmol/L (30 mg/dL), and a low-density . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?